Details

Autor(en) / Beteiligte

• Pinkos, Arleen
• Arreaza-Rubin, Guillermo
• Heetderks, William J.
• Irony, Ilan
• Joffe, Hylton V.
• Schneider, Bruce
• Zimliki, Charles L.

Titel

FDA's proactive role in the development of an artificial pancreas for the treatment of diabetes mellitus

Ist Teil von

• Drug discovery today. Technologies, 2007, Vol.4 (1), p.25-28

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2007

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• One of the critical path initiatives of the Food and Drug Administration (FDA) is to accelerate the development and availability of a safe and effective artificial pancreas for the treatment of diabetes mellitus. The FDA has established a multidisciplinary group of scientists and clinicians, in partnership with the National Institutes of Health (NIH), to address the clinical, scientific and regulatory challenges related to this unique medical product. Janet Woodcock – Food and Drug Administration, Rockville, MD, USA